Current state of metaphylaxis of urinary stones in Russian Federation


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Urolithiasis is one of the most common urological diseases in adults. Increased life expectancy of the population in developed countries, make urolithiasis topical issue and requires close attention. Due to the high risk of recurrent stone formation causing repeated surgical interventions, the issue of effective urinary stone metaphylaxis is very important today. Materials and methods. To study the current state of the problem of urolithiasis metaphylaxis among Russian urologists, an anonymous questionnaire was applied. A 25-question questionnaire was sent to e-mail to more than 4,000 Russian urologists. A total of 1,238 specialists completed the questionnaire. The database compiled from the received responses was processed and presented with descriptive statistics in the form of tables and charts. Results. According to the survey, more than half of the 831 (67.1%) specialists specialized in the treatment of urolithiasis. It was noted that 626 (86%) inpatient urologists and 205 (40%) outpatient urologists specialized in the treatment of urolithiasis. Only 521 (69.6%) urologists specializing in surgical treatment of urolithiasis give a patient a stone fragment to analyze its chemical composition. At the same time, half of the respondents reported that less than 10% of patients come to them for further metaphylaxis. One of the main reasons for not analyzing the chemical composition of the stone was the fact that 877 (70,84%) specialists indicated the inaccessibility of analysis under the state guarantee program, 503 (40,63%) specialists indicated the patient’s satisfaction with the results of minimally invasive surgical treatment and lack of sufficient motivation for further examinations. At the same time, less than 3% of specialists can perform stone analysis within the framework of the state guaranty program. 1180 (96,8%) respondents practiced the prophylaxis of recurrent calculi formation, but only 336 (28,47%) performed comprehensive metabolic examination of all patients followed by prescription of drug therapy and appropriate diet. Conclusions. Our survey revealed low involvement of urologists at the outpatient level in the process of conservative treatment and metaphylaxis of urolithiasis, low activity of urologists in performing complex metabolic study and comprehensive prevention of recurrent stone formation, low percentage of performing chemical composition analysis of stone and low activity of urologists in performing primary litholytic therapy of urate stones. Based on this analysis of the responses of most Russian urologists, it is possible to formulate recommendations to remove the obstacles to providing patients with urolithiasis with quality medical care in terms of conservative therapy and metaphylaxis of urolithiasis.

Full Text

Restricted Access

About the authors

V. A Malkhasyan

A.I.Evdokimov Moscow State University of Medicine and Dentistry

Email: vigenmalkhasyan@gmail.com
MD, Professor of the Department of Urology Moscow, Russia

M. A Gazimiev

I.M.Sechenov First Moscow State Medical University (Sechenov University)

Email: gazimiev@yandex.ru
MD, professor, Head of the National medical research urological center, Deputy Director of the Institute of Urology and Human Reproductive Health of the I.M. Sechenov First Moscow State Medical University Moscow, Russia

A. G Martov

A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University

Email: martovalex@mail.ru
Corresponding member of the Russian Academy of Sciences, MD, Professor, Head of the Department of Urology and Andrology of A.I. Burnazyan Moscow, Russia

N. K Gadzhiev

St. Petersburg State University

MD, Deputy Director for the Medical part (Urology) of the High Medical Technologies Clinic named after N.I. Pirogov St. Petersburg, Russia

S. O Sukhikh

S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department

Email: docsukhikh@gmail.ru
PhD, urologist Moscow, Russia

D. Yu Pushkar

A.I.Evdokimov Moscow State University of Medicine and Dentistry

Email: pushkardm@mail.ru
Academician of the Russian Academy of Sciences, MD, Professor, Head of the Department of Urology Moscow, Russia

References

  1. Ghani K.R., Roghmann F., Sammon J.D., Trudeau V., Sukumar S., Rahbar H., et al. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. J. Urol. 2014 Jan;191(1):90-96. doi: 10.1016/j.juro.2013.07.098. Epub 2013 Aug 7. PMID: 23933053.
  2. Pearle M.S., Calhoun E.A., Curhan G.C; Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J. Urol. 2005 Mar;173(3):848-857. doi: 10.1097/01.ju.0000152082.14384.d7. PMID: 15711292.
  3. Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev. Urol. 2010 Spring;12(2-3):e86-96. PMID: 20811557; PMCID: PMC2931286.
  4. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003 May;63(5):1817-1823. doi: 10.1046/j.1523-1755.2003.00917.x. PMID: 12675858.
  5. Scales C.D. Jr, Smith A.C., Hanley J.M., Saigal C.S.; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur. Urol. 2012 Jul;62(1): 160-165. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31. PMID: 22498635; PMCID: PMC3362665.
  6. Edvardsson V.O., Indridason O.S., Haraldsson G., Kjartansson O., Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013 Jan;83(1):146-152. doi: 10.1038/ki.2012.320. Epub 2012 Sep 19. Erratum in: Kidney Int. 2013 May;83(5):972. PMID: 22992468.
  7. Hesse A., Brandle E., Wilbert D., Kohrmann K.U., Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur. Urol. 2003 Dec;44(6):709-713. doi: 10.1016/s0302-2838(03)00415-9. PMID: 14644124.
  8. Trinchieri A., Coppi F., Montanari E., Del Nero A., Zanetti G., Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur. Urol. 2000 Jan;37(1):23-25. doi: 10.1159/000020094. PMID: 10671780.
  9. Picozzi S.C., Marenghi C., Casellato S., Ricci C., Gaeta M., Carmignani L. Management of ureteral calculi and medical expulsive therapy in emergency departments. J. Emerg Trauma Shock. 2011 Jan;4(1):70-76. doi: 10.4103/0974-2700.76840. PMID: 21633572; PMCID: PMC3097585.
  10. Gadzhiev N., Prosyannikov M., Malkhasyan V., Akopyan G., Somani B., Sivkov A., et al. Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period. World J. Urol. 2021 Oct;39(10):3939-3944. doi: 10.1007/s00345-021-03729-y. Epub 2021 May 18. PMID: 34008087.
  11. Кривонос О.В., Скачкова Е.И.., Малхасян В.А., Пушкарь Д.Ю. Состояние, проблемы и перспективы развития Российской урологической службы. Урология 2012;5:5-12
  12. Аполихин О.И., Сивков А.В., Москалева Н.Г., Солнцева Т.В. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за десятилетний период (2002-2012) по данным официальной статистики. Экспериментальная и клиническая урология 2014;2:4-12
  13. Dropkin B.M., Moses R.A., Sharma D., Pais V.M. Jr. The natural history of nonobstructing asymptomatic renal stones managed with active surveillance. J. Urol. 2015 Apr;193(4): 1265-1269. doi: 10.1016/j.juro.2014.11.056. Epub 2014 Nov 15. Erratum in: J Urol. 2015 Jul;194(1):267. PMID: 25463995.
  14. Koh L.T., Ng F.C., Ng K.K. Outcomes of long-term follow-up of patients with conservative management of asymptomatic renal calculi. BJU Int. 2012 Feb;109(4):622-625. doi: 10.1111/j.1464-410X.2011.10329.x. Epub 2011 Aug 18. PMID: 21851532.
  15. Glowacki L.S., Beecroft M.L., Cook R.J., Pahl D, Churchill D.N. The natural history of asymptomatic urolithiasis. J. Urol. 1992 Feb;147(2):319-321. doi: 10.1016/s0022-5347(17)37225-7. PMID: 1732583.
  16. Curhan G.C. Epidemiology of stone disease. Urol. Clin. North Am. 2007 Aug;34(3):287-293. doi: 10.1016/j.ucl.2007.04.003. PMID: 17678980; PMCID: PMC2693870.
  17. Fwu C.W., Eggers P.W., Kimmel P.L., Kusek J.W., Kirkali Z. Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States. Kidney Int. 2013 Mar;83(3):479-486. Doi: 10.1038/ ki.2012.419. Epub 2013 Jan 2. PMID: 23283137; PMCID: PMC3587650.
  18. Turney B.W., Reynard J.M., Noble J.G., Keoghane S.R. Trends in urological stone disease. BJU Int. 2012 Apr;109(7):1082-1087. doi: 10.1111/j.1464-410X.2011.10495.x. Epub 2011 Aug 26. PMID: 21883851.
  19. Coe F.L., Parks J.H., Asplin J.R. The pathogenesis and treatment of kidney stones. N. Engl. J. Med. 1992 Oct 15;327(16):1141-1152. Doi: 10.1056/ NEJM199210153271607. PMID: 1528210.
  20. Krambeck A.E., Lieske J.C., Li X., Bergstralh E.J., Melton L.J. 3rd, Rule A.D. Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. J. Urol. 2013 Jan;189(1):158-164. Doi: 10. 1016/j.juro.2012.09.023. Epub 2012 Nov 16. PMID: 23164393; PMCID: PMC3648841.
  21. Hiatt R.A., Dales L.G., Friedman G.D., Hunkeler E.M. Frequency of urolithiasis in a prepaid medical care program. Am. J. Epidemiol. 1982 Feb;115(2):255-265. doi: 10.1093/oxfordjournals.aje.a113297. PMID: 7058784.
  22. Strope S.A., Wolf J.S. Jr, Hollenbeck B.K. Changes in gender distribution of urinary stone disease. Urology. 2010 Mar;75(3):543-546, 546.e1. doi: 10.1016/j.urology.2009.08.007. Epub 2009 Oct 24. PMID: 19854493; PMCID: PMC3410535.
  23. Cupisti A., Pasquali E., Lusso S., Carlino F., Orsitto E., Melandri R. Renal colic in Pisa emergency department: epidemiology, diagnostics and treatment patterns.Intern. Emerg. Med. 2008 Sep;3(3):241-244. doi: 10.1007/s11739-008-0145-z. Epub 2008 Apr 24. PMID: 18437291.
  24. Saigal C.S., Joyce G., Timilsina A.R. Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005 Oct;68(4):1808-1814. doi: 10.1111/j.1523-1755.2005.00599.x. PMID: 16164658.
  25. Tiselius H.G. Who Forms Stones and Why? Eur. Urol. Suppl European Association of Urology 2011; 10(5):408-414. Doi: 10.1016/j. eursup.2011.07.002.
  26. Rule A.D., Lieske J.C., Li X., Melton L.J. 3rd, Krambeck A.E., Bergstralh E.J. The ROKS nomogram for predicting a second symptomatic stone episode. J. Am. Soc. Nephrol. 2014 Dec;25(12):2878-2886. Doi: 10.1681/ ASN.2013091011. Epub 2014 Aug 7. PMID: 25104803; PMCID: PMC4243346.
  27. Lieske J.C., Pena de la Vega.LS., Slezak J.M., Bergstralh E.J., Leibson C.L., Ho K.L., Gettman M.T. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006 Feb;69(4):760-764. doi: 10.1038/sj.ki.5000150. PMID: 16518332.
  28. Ferraro P.M., Curhan G.C., D’Addessi A., Gambaro G. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J. Nephrol. 2017 Apr;30(2):227-233. doi: 10.1007/s40620-016-0283-8. Epub 2016 Mar 11. PMID: 26969574.
  29. Dauw C.A., Yi Y.,Bierlein M.J., Yan P., Alruwaily A.F., Ghani K.R., Wolf J.S. Jr, Hollenbeck B.K., Hollingsworth J.M. Medication Nonadherence and Effectiveness of Preventive Pharmacological Therapy for Kidney Stones. J. Urol. 2016 Mar;195(3):648-652. doi: 10.1016/j.juro.2015.10.082. Epub 2015 Oct 17. PMID: 26485048.
  30. Клинические рекомендации мочекаменная болезнь МЗ РФ 2020 г. рабгруппа Мартов А.Г. и др.)
  31. Саенко В.С., Песегов С.В. Междисциплинарный подход к профилактике рецидивов мочекаменной болезни. Урология 2020;5:87-92

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies